• Skip to primary navigation
  • Skip to main content

Virtual IMMUNOLOGY2021™

May 10 - 15, 2021

  • Program
    • Monday, May 10
    • Tuesday, May 11
    • Wednesday, May 12
    • Thursday, May 13
    • Friday, May 14
    • Saturday, May 15
  • Abstracts
    • Submission Guidelines
    • Topic Categories
    • Editing or Withdrawing an Abstract
    • Abstract Publication and Citation
    • ePoster Presentation Guidelines
  • Registration
    • Code of Conduct
  • Awards
    • Career Awards
    • Meeting Awards
  • Careers
    • Jobs Board
  • Exhibitors
  • Sponsors
  • Show Search
Hide Search

Postdoctoral Fellow

St. Jude Children's Research Hospital
Memphis, Tennessee

A postdoctoral position is available in the laboratory of Dr. Stephen Gottschalk in the Department of Bone Marrow Transplant & Cell Therapy. Genetically modified T cells expressing chimeric antigen receptor (CAR T cells) have potent antitumor in patients with hematological malignancies. However, CAR T cells so far had limited antitumor activity in early phase clinical studies for patients with solid tumors. This lack of efficacy is most likely multifactorial including a limited array of targetable antigens, heterogenous antigen expression, and the immunosuppressive tumor microenvironment. In an effort to better model CAR T-cell therapy in preclinical model for solid tumors we have recently established an immune competent sarcoma model. In this model, we target the tumor associated antigen B7-H3, that is expressed on the cell surface of human and murine sarcoma cells.  We have successfully generated murine B7-H3-CAR T cells and have shown that these cells have – albeit modest – antitumor activity, closely mimicking human disease. In the proposed project we now want to perform mechanistic studies and perform a ‘candidate gene screen’ as well as a CRISPR/Cas9 in vivo screen in close collaboration with the Chi Lab at St Jude to discover genes that improve or impede T cell function. One major focus of this project is to better understand how transferred cells interact with the tumor microenvironment, and resident immune cells. Ultimate goal of these studies is to translate these approaches into early Phase clinical testing. 

Successful applicants will have a strong publication record, excellent communication skills, and a Ph.D. or equivalent degree in molecular biology, cell biology, genetics, genomics, immunology, or a related area. To succeed in this position, you will have a strong immunology and cell biology background, with an emphasis on cellular immunology, and genetic manipulation of murine cells. Applicants with experience in generating and evaluating murine immune cells, gene editing, and/or immune competent murine models are strongly encouraged to apply.

For more information contact Enolia Marr at postdoc@stjude.org.

« Postdoctoral Fellow
Postdoctoral Fellow »

Written by:
Dale Bengston
Published on:
Monday, May 3, 2021

Discover more


AAI Logo

Not a Member?

Join AAI Now!

Footer

Virtual
IMMUNOLOGY2021™

May 10—15, 2021

Copyright © 2025 The American Association of Immunologists, Inc.

  • Facebook
  • LinkedIn
  • Twitter
  • Code of Conduct
  • Privacy Policy
  • Press Policy
We use cookies on this site to enhance your user experience. We do not store personal data in cookies. For more information about the use of cookies on this site, please review our Privacy Policy page. I Understand
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Meeting Awards

Meeting awards are closed.

Philadelphia Hotels

Hotel booking will be available in July 2020.

Check back frequently for updates.

Abstract Submission

Abstract submission is closed.

Late-breaking abstract submission opens February 9.